BioSpace News Archive

Wilmington, Delaware, United States: According to the report, the global polymerase chain reaction market was valued at US$ 4.1 Mn in 2020 and is projected to expand at a CAGR of 6.4% from 2021 to 2028.

Sensorion a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat and prevent within the field of hearing loss disorders, is pleased to announce the participation in-person of members of Sensorion’s senior management in the Inner Ear Disorder Therapeutics Summit, a scientific conference being held in Boston, USA, in June 2022.

Allmed Medical GmbH, part of Allmed Group, a producer of end-to-end haemodialysis solutions, announces that it has received Medical Device Regulation certification from its Notified Body, the British Standards Institution, ensuring continuous market access of the Company’s haemodialysis products in Europe.

Lonza, a global development and manufacturing partner to the pharma, biotech and nutrition industries, and French pharmaceutical group Pierre Fabre announced that the companies have entered into a manufacturing agreement.

Global Access Health, a social enterprise dedicated to providing affordable medical products for global health, formally introduced its first portfolio company, Global Access Diagnostics.

AlzeCure Pharma AB announced that the study plan for the planned Phase II clinical study in neuropathic pain with ACD440, the leading non-opioid drug candidate in the Painless platform, is now available on ClinicalTrials.gov.

Owen Mumford, a global leader in the design, manufacture and advancement of medical devices announced that it has appointed Bal Johal as Director of Research and Development, effective from 4th July 2022.

Wilmington, Delaware, United States: The heparin market is estimated to experience significant growth opportunities in the upcoming years.

Antibody-Drug Conjugates contract manufacturing is putting in place systems to deal with difficult supply chains, as well as infrastructure and processes to ensure security, quality, and efficiency.

Fact.MR – A Market Research and Competitive Intelligence Provider: The market demand for Cochlear Implant is expected to rise steadily on the back of growing public awareness, breakthroughs in cochlear implants, increasing implant penetration due to market participants extended geographical reach, and favourable government efforts.